FrancophonIA/ELRC3.0 huggingface dataset:
English: • inflammation of the liver
Estonian: • kõhulahtisus.
English: Immune-related diarrhoea or colitis, defined as requiring use of corticosteroids with no clear alternate aetiology, has been observed in patients receiving cemiplimab (see section 4.8).
Estonian: Tsemiplimabiga ravitud patsientidel on täheldatud immuuntekkelist koliiti või diarröad, mis on määratletud kui kortikosteroidide manustamist vajav ja ilma selge etioloogiata (vt lõik 4.8).
English: Resume LIBTAYO if nephritis improves and remains at Grade 0 to 1 after corticosteroid taper to ≤10 mg/day prednisone or equivalent
Estonian: Jätkata LIBTAYO manustamist, kui nefriit paraneb ja püsib vahemikus 0 kuni 1. raskusaste pärast kortikosteroidi annuse vähendamist ≤ 10 mg/ööpäev prednisoonina või samaväärsena.
English: Immune-related nephritis, defined as requiring use of corticosteroids with no clear alternate aetiology, has been observed in patients receiving cemiplimab (see section 4.8).
Estonian: Tsemiplimabiga ravitud patsientidel on täheldatud immuuntekkelist nefriiti, mis on määratletud kui kortikosteroidide manustamist vajav ja ilma selge etioloogiata (vt lõik 4.8).
English: In order to confirm the efficacy and safety of cemiplimab for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation, the MAH should provide interim data of a single-arm trial in the same population [study 1540 group 6].
Estonian: Müügiloa hoidja peab esitama vaheandmed kontrollrühmata uuringu sama populatsiooni kohta (uuring 1540, 6. rühm), et kinnitada tsemiplimabi efektiivsust ja ohutust naha metastaatilise või lokaalse kaugelearenenud lamerakk-kartsinoomi ravis patsientidel, kellele kuratiivne kirurgiline või kuratiivne kiiritusravi ei sobi.
English: Mix the diluted solution by gentle inversion.
Estonian: Lahjendatud lahust tuleb segada infusioonikotti õrnalt ümber pöörates.
English: Resume LIBTAYO if colitis or diarrhoea improves and remains at Grade 0 to 1 after corticosteroid taper to ≤10 mg/day prednisone or equivalent
Estonian: Jätkata LIBTAYO manustamist, kui koliit või diarröa paraneb ja püsib vahemikus 0 kuni 1. raskusaste pärast kortikosteroidi annuse vähendamist ≤ 10 mg/ööpäev prednisoonina või samaväärsena.
English: • rash, itching
Estonian: • lööve, sügelus;
English: Resume LIBTAYO if skin reaction improves and remains at Grade 0 to 1 after corticosteroid taper to ≤10 mg/day prednisone or equivalent
Estonian: Jätkata LIBTAYO manustamist, kui nahareaktsioon paraneb ja püsib vahemikus 0 kuni 1. raskusaste pärast kortikosteroidi annuse vähendamist ≤ 10 mg/ööpäev prednisoonina või samaväärsena.
English: Immune-related skin adverse reactions
Estonian: Immuuntekkelised naha kõrvaltoimed
English: Recommended dose
Estonian: Infolehe sisukord
English: 1.33 ml (150 mg/ml)
Estonian: 1,33 ml (150 mg/ml) 2 viaali
English: 200 mg Concentrate for solution for infusion
Estonian: 200 mg Infusioonilahuse kontsentraat
English: MA (EU) number (Invented) name
Estonian: (Väljamõel dud) nimetus
English: Intravenous use vial (glass)
Estonian: Intravenoosne klaasviaal
English: United Kingdom Teva United Kingdom Limted
Estonian: Teva United Kingdom Limted
English: List of the names, pharmaceutical form(s), strength(s) of the medicinal product(s), route(s) of administration, marketing authorisation holder(s) in the member states
Estonian: LISA I RAVIMI(TE) NIMETUSTE, RAVIMVORMI(DE), TUGEVUS(T)E, MANUSTAMISVIISI(DE), MÜÜGILOA HOIDJA(TE) LOETELU LIIKMESRIIKIDES
English: United Kingdom Crescent Pharma Limited Units 3 & 4
Estonian: Crescent Pharma Limited Units 3 & 4
English: United Kingdom Generics (United Kingdom) Limited
Estonian: Generics (United Kingdom) Limited
English: Station Close, Potters Bar Hertfordshire EN6 1TL
Estonian: Station Close, Potters Bar Hertfordshire EN6 1TL United Kingdom
English: 1526 Ljubljana
Estonian: 1526 Ljubljana Slovenia
English: 1000 Ljubljana
Estonian: 1000 Ljubljana Slovenia
English: 82102 Bratislava
Estonian: 82102 Bratislava Slovakia
English: Str. Logofăt Tăutu, nr. 99 sector 3, Bucureşti 031212 Romania
Estonian: Str. Logofăt Tăutu, nr. 99 sector 3, Bucureşti 031212
English: Finland sanofi-aventis Oy Huopalahdentie 24 00350 Helsinki Finland
Estonian: Soome sanofi-aventis Oy Huopalahdentie 24 00350 Helsinki Finland
English: Polhampton Lane, Overton Hampshire RG25 3ED
Estonian: Polhampton Lane, Overton Hampshire RG25 3ED United Kingdom
English: United Kingdom Chelonia Healthcare Limited
Estonian: Chelonia Healthcare Limited
English: ARENA GROUP S.A Str. Stefan Mihaileanu, nr.31 sector 2; Bucuresti 024022 România
Estonian: S.C. ARENA GROUP S.A Str. Stefan Mihaileanu, nr.31 sector 2; Bucuresti 024022 România
English: Luxembourg Nycomed Belgium s.a. 615, chaussee de Gand B-1080 Bruxelles
Estonian: Nycomed Belgium s.a. 615, chaussee de Gand B-1080 Bruxelles Belgium
English: Hampden Park, Eastbourne East Sussex BN22 9AG United Kingdom
Estonian: Brampton Road Hampden Park, Eastbourne East Sussex BN22 9AG United Kingdom
English: United Kingdom Pharmvit Limited 177 Bilton Road, Perivale Middlesex UB6 7HQ United Kingdom
Estonian: Pharmvit Limited 177 Bilton Road, Perivale Middlesex UB6 7HQ United Kingdom
English: 3542 DR Utrecht The Netherlands
Estonian: Computerweg 10 3542 DR Utrecht The Netherlands
English: Paspertin 50 mg - Konzentrat zur Infusionsbereitung
Estonian: Paspertin 50 mgKonzentrat zur Infusionsbereitung
English: Accord Healthcare B.V. De Waterman 15 A 4891 TL Rijsbergen The Netherlands
Estonian: De Waterman 15 A 4891 TL Rijsbergen The Netherlands
English: Radlická 3185/1c
Estonian: Radlická 3185/1c 150 00 Prague Czech Republic
English: United Kingdom Mercury Pharma International Limited 4045 Kingswood Raod City West Business Park County Dublin
Estonian: Mercury Pharma International Limited 4045 Kingswood Raod City West Business Park County Dublin Ireland
English: Gloucester GL3 4AG
Estonian: Gloucester GL3 4AG United Kingdom
English: PROKINYL L.P. 15 mg, gélule à libération prolongée
Estonian: 15 mg, gélule à libération prolongée
English: D-89079 Ulm mcP Ratiopharm SF
Estonian: D-89079 Ulm Germany mcP Ratiopharm SF
English: Slovak Republic TEVA Pharmaceuticals Slovakia s.r.o.
Estonian: TEVA Pharmaceuticals Slovakia s.r.o.
English: Alexandriei, nr 145 A B07-Bragadiru, jud Ilfov România
Estonian: B07-Bragadiru, jud Ilfov România
English: ANAUSIN METOCLOPRAMIDE 15 mg, comprimé à libération prolongée
Estonian: METOCLOPRAMIDE 15 mg, comprimé à libération prolongée
English: Str. Aleea Eroilor nr. 28, Vişeu de Sus, Judeţul Maramureş 435700 România
Estonian: Vişeu de Sus, Judeţul Maramureş 435700
English: Luxembourg Eurogenerics s.a. Heizel Esplanade B22
Estonian: Eurogenerics s.a. Heizel Esplanade B22 1020 Laeken Belgium
English: 83-200 Starogard Gdański Poland
Estonian: Pelplińska 19 83-200 Starogard Gdański
English: Pharmaceutical Works POLPHARMA SA 19 Pelplińska Street 83-200 Starogard Gdański Poland
Estonian: 19 Pelplińska Street 83-200 Starogard Gdański
English: Primperan 20, zetpillen 20 mg 20mg
Estonian: Primperan 20, zetpillen 20 mg
English: Czech Republic Teva Pharmaceuticals CR, s.r.o.
Estonian: Teva Pharmaceuticals CR, s.r.o.
English: United Kingdom Metwest Pharmaceuticals Limited
Estonian: Metwest Pharmaceuticals Limited
English: United Kingdom Rosemont Pharmaceuticals Limited
Estonian: Rosemont Pharmaceuticals Limited
English: Primperan 10, zetpillen 10 mg 10mg
Estonian: Primperan 10, zetpillen 10 mg
English: Modified-release capsule, soft
Estonian: Toimeainet modifitseeritult vabastav pehmekapsel
English: United Kingdom Ennogen Limited 78 York Street
Estonian: Ennogen Limited 78 York Street London W1H 1DP United Kingdom
English: MCP-CT 30mg Retardkapseln 30mg
Estonian: MCP-CT 30mg Retardkapseln
English: Medochemie Limited 1-10 Constantinoupleos Str
Estonian: Medochemie Limited 1-10 Constantinoupleos Str 3011 Limassol Cyprus
English: Boumpoulinas 11, 3rd Floor
Estonian: Boumpoulinas 11, 3rd Floor Nicosia, CY-1060
English: United Kingdom Hameln Pharmaceuticals Limited
Estonian: Hameln Pharmaceuticals Limited
English: MCP Ratiopharm-30
Estonian: MCP Ratiopharm-30 30 mg
English: 01445 Radebeul
Estonian: 01445 Radebeul Germany
English: D-89079 Ulm
Estonian: D-89079 Ulm Germany
English: Yorkdale Industrial Park Braithwaite Street
Estonian: Rosemont House Yorkdale Industrial Park Braithwaite Street Leeds, W Yorkshire LS11 9XE
English: Nexus, Gloucester
Estonian: Nexus, Gloucester Business Park
English: Miles Gray Road, Basildon Essex SS14 3AF
Estonian: Amdipharm plc Regency House Miles Gray Road, Basildon Essex SS14 3AF United Kingdom
English: Modified-release capsules, hard
Estonian: Toimeainet modifitseeritult vabastavad kõvakapslid
English: Oral solution betapharm Arzneimittel GmbH
Estonian: Suukaudne lahus betapharm Arzneimittel GmbH
English: Slovak Republic Sandoz Pharmaceuticals d.d.
Estonian: Sandoz Pharmaceuticals d.d.
English: Luxembourg Sanofi-Aventis Belgium Culliganlaan 1 C
Estonian: Sanofi-Aventis Belgium Culliganlaan 1 C 1831 Diegem Belgium
English: Paspertin 50mg/10ml Ampullen 50mg/10ml
Estonian: Paspertin 50mg/10ml Ampullen
English: MCP Tropfen-1 A-Pharma
Estonian: MCP Tropfen-1 A-Pharma 4,21 mg/1 g
English: 20 mg/spray
Estonian: 20 mg/pihustus
English: 10 mg/spray
Estonian: 10 mg/pihustus
English: United Kingdom Actavis UK Limited Whiddon Valley
Estonian: Actavis UK Limited Whiddon Valley Barnstaple North evon EX32 8NS United Kingdom
English: Teva Pharma B.V. Computerweg 10
Estonian: Teva Pharma B.V.
English: Degan 10 mg tablety
Estonian: Degan 10 mg tablety 10 mg
English: Elitan injection 10mg/2ml
Estonian: Elitan injection 10mg/2ml 10 mg/2 ml
English: Cloperan tablets 10mg
Estonian: Cloperan tablets 10mg 10 mg
English: Maxolon Tablets 10mg
Estonian: Maxolon Tablets 10mg 10 mg
English: Suppository
Estonian: Suposiit
English: MCP-CT 10mg/2ml Ampullen 10mg/2ml
Estonian: MCP-CT 10mg/2ml Ampullen
English: Oral drops, solution
Estonian: Ninasprei, lahus
English: MCP Sandoz 10mg Tabletten 10.53mg
Estonian: MCP Sandoz 10mg Tabletten
English: Reglan 10 mg tablete
Estonian: Reglan 10 mg tablete 10 mg
English: Primperan tablets 10mg
Estonian: Primperan tablets 10mg 10 mg
English: MCP Heumann 10mg Tabletten 10.53mg
Estonian: MCP Heumann 10mg Tabletten
English: Paspertin 10mg/2ml Ampullen 10mg/2ml
Estonian: Paspertin 10mg/2ml Ampullen
English: Cerucal 10 mg tablets
Estonian: Cerucal 10 mg tablets 10 mg
English: Paspertin - Filmtabletten
Estonian: Paspertin - Filmtabletten 10 mg
English: Rectal use ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Estonian: Rektaalne ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
English: Metoclopramide EG-10
Estonian: Metoclopramide EG-10 10 mg
English: Prolonged-release tablet Oral use
Estonian: Toimeainet prolongeeritult vabastav tablett
English: Zakłady Farmaceutyczne Polpharma SA ul.
Estonian: Pharmaceutical Works POLPHARMA SA
English: MCP AbZ 5 mg/ml Tropfen 5.91mg/ml
Estonian: MCP-CT 4mg/1ml Tropfen 5,2 mg/ml
English: Intramuscular use Intravenous use
Estonian: Infusioonilahuse kontsentraat
English: Middlesex HA1 3NY
Estonian: 15 Runnelfield Harrow on the Hill Middlesex HA1 3NY United Kingdom
English: Metoclopramide Tablets 10mg 10mg
Estonian: Metoclopramide Tablets 10mg
English: Prolonged-release capsule, hard
Estonian: Toimeainet prolongeeritult vabastav kõvakapsel
English: S.C. MEDUMAN S.A.
Estonian: S.C. MEDUMAN S.A. Str. Aleea Eroilor nr. 28,
English: Prolonged-release capsule ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
Estonian: Toimeainet prolongeeritult vabastav kapsel ratiopharm GmbH Graf-Arco-Str. 3 D-89079 Ulm Germany
English: Metoclopramidemonohydrochlor ide Accord 10 mg Tabletten
Estonian: Metoclopramidemonohy drochloride Accord 10 mg Tabletten
English: 83607 Holzkirchen Germany
Estonian: Industriestrasse 25 83607 Holzkirchen Germany
English: Gastrosil retard mite
Estonian: Gastrosil retard mite 15,8 mg
English: Metoclopramide 10 mg tablets 10mg
Estonian: Metoclopramide 10 mg tablets
English: Luxembourg Dolorgiet Gmbh&Co Otto-von-Guericke-Str. 1
Estonian: Dolorgiet Gmbh&Co Otto-von-Guericke-Str. 1 D-53757 Sankt Augustin Germany
English: Metogastron 4 mg/ml - Tropfen 4mg/ml
Estonian: MCP Hexal Tropfen 4 mg/ml
English: Metoclopramide 10mg Tablets 10mg
Estonian: Metoclopramide 10mg Tablets
English: Rectal use
Estonian: Rektaalne
English: Paspertin 4 mg/ml - Tropfen 4mg/ml
Estonian: Paspertin 4 mg/mlTropfen
English: Luxembourg Ratiopharm GMBH Arzneimittel
Estonian: Ratiopharm GMBH Arzneimittel Graf-Arco-Str. 3
English: MCP Ratiopharm
Estonian: MCP Ratiopharm 10 mg
English: Maxolon Paediatric Liquid
Estonian: Maxolon Paediatric Liquid 5 mg/5 ml
English: METOCLOPRAMID LAROPHARM 10mg
Estonian: METOCLOPRAMID LAROPHARM
English: Metoclopramidum Polpharma 10mg
Estonian: Metoclopramida Labesfal 10 mg
English: MCP STADA 10 mg Tabletten 10.53mg
Estonian: Gastrosil Tabletten 10,54 mg
English: Long-term exposure (at least 48 weeks)
Estonian: Pikaajaline avaldumine (vähemalt 48 nädalat)
English: You and your doctor should check your weight regularly.
Estonian: Te peaksite koos arstiga regulaarselt oma kaalu jälgima.
English: Try to take your tablets at the same time each day.
Estonian: Püüdke tablett manustada iga päev ühel ja samal ajal.
English: There are no adequate and well-controlled studies in pregnant women.
Estonian: Rasedatega ei ole läbi viidud adekvaatseid ja hästi kontrollitud uuringuid.
English: Do not take a double dose to make up for the forgotten tablet.
Estonian: Ärge võtke unustatud tableti korvamiseks kahekordset annust.
English: Show the doctor your pack of tablets.
Estonian: Näidake arstile oma tablettide pakendit.
English: DATE OF REVISION OF THE TEXT {MM/YYYY}
Estonian: TEKSTI LÄBIVAATAMISE KUUPÄEV {KK/AAAA}
English: Close medical supervision and monitoring should continue until the patient recovers.
Estonian: Tähelepanelik meditsiiniline järelevalve ja jälgimine peab jätkuma seni, kuni patsient paraneb.
English: Package leaflet: Information for the user
Estonian: PAKENDI INFOLEHT: TEAVE KASUTAJALE
English: Information on long term safety is primarily limited to open-label, uncontrolled data.
Estonian: Andmed pikaajalise ohtuse kohta piirduvad eeskätt avatud mittekontrollitud andmetega.
English: Consequently, newborns should be monitored carefully.
Estonian: Seetõttu tuleb vastsündinuid hoolikalt jälgida.
English: Patients should be closely monitored during this period.
Estonian: Selle aja kestel tuleb patsienti hoolikalt jälgida.
English: Some fatal cases have been reported in this particular group of patients.
Estonian: Selles patsiendigrupis on esinenud üksikuid surmajuhtumeid.
English: There are no controlled data on maintenance of effect or long term safety (see sections 4.4 and 4.8).
Estonian: Puuduvad kontrollitud andmed tõhususe säilitamise või pikaajalise ohutuse kohta (vt lõigud 4.4 ja 4.8).
English: Interaction studies have only been performed in adults.
Estonian: Koostoime uuringuid on läbiviidud ainult täiskasvanute seas.
English: After first opening use within 90 days.
Estonian: Pärast esmast avamist kasutada 90 päeva jooksul.
English: Your doctor may suggest you to reduce the dose gradually before stopping treatment.
Estonian: Teie arst võib Teil soovitada enne ravi lõpetamist annust järk-järgult vähendada.
English: • Medicines of this type may cause unusual movements mainly of the face or tongue.
Estonian: • Seda tüüpi ravimid võivad põhjustada peamiselt näo või keele ebaharilikke liigutusi.
English: It does not matter whether you take them with or without food.
Estonian: See ei oma tähtsust, kas võtate tabletti koos toiduga või ilma.
English: Decreased libido in males and females
Estonian: Libiido langus meestel ja naistel
English: However, the marketing authorisation holder shall submit periodic safety update reports for this medicinal product if the product is included in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal.
Estonian: Müügiloa hoidja peab esitama ravimi perioodilisi ohutusaruandeid juhul, kui ravim on lisatud direktiivi 2001/83/EÜ artikli 107c punktis 7 sätestatud ja Euroopa ravimite veebiportaalis avaldatud liidu kontrollpäevade loetellu.
English: Tell your doctor if you are taking, have recently taken or might take any other medicines.
Estonian: Teatage oma raviarstile, kui kui te võtate või olete hiljuti võtnud või kavatsete võtta mis tahes muid ravimeid
English: Bottles: After first opening use within 90 days.
Estonian: Pudelid: Pärast esmast avamist kasutada 90 päeva jooksul.
English: A lower starting dose (5 mg) should be considered for such patients.
Estonian: Sellistel patsientidel tuleb kaaluda väiksemat algannust (5 mg).
English: In the majority of these patients the elevations were generally mild, and remained below two times the upper limit of normal range.
Estonian: Enamikul nendest patsientidest oli suurenemine üldiselt vähene ja jäi allapoole kahekordsest normväärtuse ülemisest piirist.
English: Additional information on special populations
Estonian: Lisainformatsioon eripopulatsioonide kohta
English: Discontinuation symptoms7, 12
Estonian: Ravi katkestamise sümptomid7, 12
English: Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them.
Estonian: Nii nagu kõik ravimid, võib ka see ravim põhjustada kõrvaltoimeid, kuigi kõigil neid ei teki.
English: • if you have been previously diagnosed with eye problems such as certain kinds of glaucoma (increased pressure in the eye).
Estonian: • Kui teil on diagnoositud probleeme silmadega, nagu nt kindlad glaukoomi vormid (suurenenud surve silmas).
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Estonian: Täpne informatsioon selle ravimpreparaadi kohta on Euroopa Ravimiameti kodulehel http://www.ema.europa.eu/.
English: This will usually pass on its own but if it does not, tell your doctor.
Estonian: Tavaliselt möödub see iseenesest, aga kui seda ei juhtu, siis konsulteerige raviarstiga.
English: Gerard Laboratories, 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13, Ireland Generics [UK] Limited, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom.
Estonian: Tootja: Gerard Laboratories, 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13, Iirimaa Generics [UK] Limited, Station Close, Potters Bar, Hertfordshire, EN6 1TL, Ühendkuningriik.
English: • Tell the doctor if you or someone else in your family has a history of blood clots, as medicines like these have been associated with the formation of blood clots.
Estonian: • Öelge oma arstile, kui teil või kellelgi teie perekonnast on esinenud verehüübeid, kuna selliseid ravimeid seostatakse verehüüvete tekkimisega.
English: If this happens do not drive or operate any tools or machines.
Estonian: Kui see peaks esinema, siis ärge juhtige autot ega käsitsege tööriistu ega masinaid.
English: During antipsychotic treatment, improvement in the patient's clinical condition may take several days to some weeks.
Estonian: Patsiendi kliinilise seisundi paranemine antipsühhootilise ravi jooksul võib saabuda mõne päeva kuni mõne nädala jooksul.
English: Increased total bilirubin
Estonian: Suurenenud bilirubiini hulk
English: Fertility Effects on fertility are unknown (see section 5.3 for preclinical information).
Estonian: Fertiilsus Toime fertiilsusele ei ole teada (vt prekliinilist informatsiooni lõigust 5.3).
English: Adolescents (ages 13 to 17 years): The pharmacokinetics of olanzapine are similar between adolescents and adults.
Estonian: Noorukid (vanuses 13-17 aastat): Olansapiini farmakokineetika noorukite ja täiskasvanute vahel on sarnane.
English: A mass balance study showed that approximately 57 % of radiolabelled olanzapine appeared in urine, principally as metabolites.
Estonian: Massi tasakaalu uuringust nähtus, et ligikaudu 57 % radioaktiivselt märgistatud olansapiinist esines uriinis, peamiselt metaboliitidena.
English: However, the magnitude of the impact of age, gender, or smoking on olanzapine clearance and half-life is small in comparison to the overall variability between individuals.
Estonian: Sellegipoolest on vanuse, soo või suitsetamise mõju olansapiini kliirensile ja poolväärtusajale väike, võrreldes üldise indiviididevahelise varieeruvusega.
English: The mean increase in olanzapine AUC was 52 % and 108 % respectively.
Estonian: Olansapiini AUC tõusis keskmiselt vastavalt 52 % ja 108 % võrra.
English: People with this disease may also feel depressed, anxious or tense.
Estonian: Seda haigust põdevad inimesed võivad tunda ka masendust, ärevust või pinevust.
English: Tell your doctor immediately if you have:
Estonian: Öelge koheselt oma arstile, kui teil tekivad:
English: Such factors possibly contribute to the higher average exposure observed in adolescents.
Estonian: Need faktorid põhjustavad tõenäoselt noorukitel täheldatud kõrgemat toimeaine ekspositsiooni.
English: In some cases, a prior increase in body weight has been reported which may be a predisposing factor.
Estonian: Mõnedel juhtudel on täheldatud eelnevat ülekaalulisust, mis võib olla seda soodustavaks teguriks.
English: Demographic differences between the adolescents and adults include a lower average body weight and fewer adolescents were smokers.
Estonian: Demograafilised erinevused noorukite ja täiskasvanute vahel on keskmine kehakaal ning noorukite seas esineb vähem suitsetajaid.
English: Absolute oral bioavailability relative to intravenous administration has not been determined.
Estonian: Absoluutset suukaudset biosaadavust intravenoosse manustamise suhtes ei ole määratud.
English: The median lethal doses were approximately 210 mg/kg (mice) and 175 mg/kg (rats).
Estonian: Keskmine surmav annus oli ligikaudu 210 mg/kg (hiirtel) ja 175 mg/kg (rottidel).
English: • unusual movement (a common side effect that may affect up to 1 in 10 people) mainly of the face or tongue;
Estonian: • Ebatavalised liigutused (sageliesinev kõrvaltoime, mis võib tekkida kuni 1 inimesel 10st), need on peamiselt näo ja keele liigutused;
English: These symptoms can temporally deteriorate or even arise after discontinuation of treatment.
Estonian: Need sümptomid võivad pärast ravi lõppu ajutiselt süveneda või alles tekkida.
English: Activated charcoal reduces the bioavailability of oral olanzapine by 50 % to 60 % and should be taken at least 2 hours before or after olanzapine.
Estonian: Aktiveeritud süsi vähendab suukaudse olansapiini biosaadavust 50 kuni 60 % võrra ning seda tuleks manustada vähemalt 2 tundi enne või pärast olansapiini.
English: The starting dose and dose range need not be routinely altered for non-smokers relative to smokers.
Estonian: Algannust ja annuste vahemikku ei ole tavaliselt vaja mittesuitsetajatel muuta, võrreldes suitsetajatega.
English: Very rare side effects include serious allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
Estonian: Väga harva esinevate kõrvalnähtude hulka kuuluvad rasked allergilised reaktsioonid, nt eosinofiilia ja süsteemsed sümptomid (DRESS).
English: • Stroke or “mini” stroke (temporary symptoms of stroke)
Estonian: • Ajuinsult või “mini” ajuinsult (ajutised insuldi sümptomid)
English: In particular, tell your doctor if you are taking:
Estonian: Eriti oluline on arstile rääkida, kui te võtate:
English: 117 Allée des Parcs 69800 Saint-Priest France
Estonian: 117 Allée des Parcs 69800 Saint-Priest Prantsusmaa
English: The higher incidence of death was not associated with olanzapine dose (mean daily dose 4.4 mg) or duration of treatment.
Estonian: Suurem suremus ei olnud seotud olansapiini annusega (keskmine ööpäevane annus 4,4 mg) ega ravi kestusega.
English: Speech disorder was also reported commonly.
Estonian: Samuti registreeriti sageli kõnehäiret.
English: Caution should be exercised in patients who consume alcohol or receive medicinal products that can cause central nervous system depression.
Estonian: Tähelepanelik tuleb olla patsientidega, kes manustavad alkoholi või saavad ravimeid, mis põhjustavad kesknärvisüsteemi depressiooni.